A clinical trial to study effect of kushmanda churna in children with epilepsy.

Evaluation of Kushmanda Churna In Management Of Epilepsy In Children As An Add-On Therapy- A Randomized Controlled Clinical Trial. - Nil

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065882

Enrollment

Registered

2024-04-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G409- Epilepsy, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients from either sex in age group between 5-16 years. Patients fulfilling the diagnostic criteria will be included for the study. Epilepsy of any origin. Patients on conventional antiepileptic therapy.

Exclusion criteria

Exclusion criteria: Patients with any life-threatening congenital anomalies like congenital heart disease (CHD) etc. will be excluded. Patients with other disease status like Acute infections, severe systemic illness etc. will be. excluded from the study. Patients with severe debilitating illnesses like mental retardation, spastic quadriplegia etc.

Design outcomes

Primary

Measure	Time frame
There might be significant effect of Kushmand churna in children with conventional antiepileptic therapy.Timepoint: 0 day 30 days 60 days	—

Secondary

Measure	Time frame
Quality of Life in Childhood Epilepsy Questionnaire Global assessment of the severity of epilepsy Scale THE NATIONAL HOSPITAL SEIZURE SEVERITY SCALETimepoint: 0 day 30th day 60th day	—

Countries

India

Contacts

Public ContactDr Veena Tonne

KLE Shri B.M.Kankanwadi Ayurveda Mahavidyalaya, Belagavi,

dr.veenatonne@gmail.com09538469641

Outcome results